(Q33236308)

24 July 2017

1 reference

title

Oncology exploration: charting cancer medicinal chemistry space (English)

1 reference

24 July 2017

Darren Fayne

4

0 references

David Lloyd

object named as

David G Lloyd

1

0 references

Tudor I Oprea

object named as

Tudor I Oprea

6

0 references

author name string

Georgia Golfis

2

1 reference

24 July 2017

Andrew J S Knox

3

1 reference

24 July 2017

Mary J Meegan

5

1 reference

24 July 2017

publication date

1 February 2006

1 reference

24 July 2017

1 reference

24 July 2017

volume

11

1 reference

24 July 2017

issue

3-4

1 reference

24 July 2017

page(s)

149-159

1 reference

Bioinformatics and cancer target discovery

24 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903688-3

7 January 2021

Exploiting novel cell cycle targets in the development of anticancer agents.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903688-3

7 January 2021

Recent anticancer cytotoxic agents

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903688-3

7 January 2021

The search of DNA-intercalators as antitumoral drugs: what it worked and what did not work.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903688-3

7 January 2021

Molecular therapeutic approaches to acute myeloid leukemia: targeting aberrant chromatin dynamics and signal transduction.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903688-3

7 January 2021

Identification of cancer genes by mutational profiling of tumor genomes

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903688-3

7 January 2021

Development of molecular targeted anticancer agents: successes, failures and future directions

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903688-3

7 January 2021

Anticancer Antifolates: Current Status and Future Directions

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903688-3

7 January 2021

Cytotoxic activity of 6-alkynyl- and 6-alkenylpurines

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903688-3

7 January 2021

The prodrugs of 5-fluorouracil

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903688-3

7 January 2021

Intercalators as anticancer drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903688-3

7 January 2021

Catalytic topoisomerase II inhibitors in cancer therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903688-3

7 January 2021

Rational approaches to the design of therapeutics targeting molecular markers: the case of chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903688-3

7 January 2021

Cancer gene discovery in solid tumours using transposon-based somatic mutagenesis in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903688-3

7 January 2021

Kinomics: characterizing the therapeutically validated kinase space.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903688-3

7 January 2021

Imatinib as a paradigm of targeted therapies

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903688-3

7 January 2021

Proteasome inhibition as a therapeutic strategy for hematologic malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903688-3

7 January 2021

Mechanism of action of antitumor drugs that interact with microtubules and tubulin

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903688-3

7 January 2021

Advances in the science of estrogen receptor modulation

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903688-3

7 January 2021

Benzoxepin-derived estrogen receptor modulators: a novel molecular scaffold for the estrogen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903688-3

7 January 2021

A transmembrane intracellular estrogen receptor mediates rapid cell signaling

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903688-3

7 January 2021

Androgen receptor as a target in androgen-independent prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903688-3

7 January 2021

Pharmacology of antiandrogens and value of combining androgen suppression with antiandrogen therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903688-3

7 January 2021

Aromatase inhibitors: a new paradigm in breast cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903688-3

7 January 2021

Aromatase inhibitors for therapy of advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903688-3

7 January 2021

Toward designing drug-like libraries: a novel computational approach for prediction of drug feasibility of compounds

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903688-3

7 January 2021

Virtual screening: a real screening complement to high-throughput screening

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903688-3

7 January 2021

Recent development and application of virtual screening in drug discovery: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903688-3

7 January 2021

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903688-3

7 January 2021

A ‘Rule of Three’ for fragment-based lead discovery?

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903688-3

7 January 2021

Molecular recognition: the fragment approach in lead generation.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903688-3

7 January 2021

The in silico world of virtual libraries

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903688-3

7 January 2021

Design and synthesis of protein superfamily-targeted chemical libraries for lead identification and optimization

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903688-3

7 January 2021

Strategies for compound selection

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903688-3

7 January 2021

Focused combinatorial library design based on structural diversity, druglikeness and binding affinity score

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903688-3

7 January 2021

Current trends in lead discovery: are we looking for the appropriate properties?

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903688-3

7 January 2021

Structure-based virtual screening: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903688-3

7 January 2021

Property distribution of drug-related chemical databases.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903688-3

7 January 2021

Design of a compound screening collection for use in high throughput screening

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903688-3

7 January 2021

Pursuing the leadlikeness concept in pharmaceutical research.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903688-3

7 January 2021

Prediction of 'drug-likeness'.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903688-3

7 January 2021

Drug-like properties and the causes of poor solubility and poor permeability

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903688-3

7 January 2021

A New Atom-Additive Method for Calculating Partition Coefficients

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903688-3

7 January 2021

Chemography: the art of navigating in chemical space.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903688-3

7 January 2021

ZINC--a free database of commercially available compounds for virtual screening

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903688-3

7 January 2021

Mapping chemical space using molecular descriptors and chemical genetics: deacetylase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903688-3

7 January 2021

10.1016/S1359-6446(05)03688-3

Identifiers

DOI

1 reference

24 July 2017

1 reference